News
Drug-eluting balloons have been plagued, for years, by flawed technology and undersized trials. But some experts believe they are the best way forward for in-stent restenosis and that skeptical ...
The Onyx Frontier™ drug-eluting stent offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent DUBLIN, May 13 ...
Medtronic plc MDT announced the receipt of the FDA approval for the Onyx Frontier drug-eluting stent (DES). The Onyx Frontier DES is utilized for treating patients with coronary artery disease (CAD).
Covina, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Drug Eluting Stent Market accounted for US$ 7.5 billion in 2022 and is estimated to be US$ 14.02 billion by 2032 and is anticipated to register a CAGR of ...
Medtronic drug-eluting stents net FDA approval for treating complex clogs at coronary artery junctions By Conor Hale Sep 21, 2022 11:38am ...
New-generation drug-eluting stents (DES) utilize various drugs, polymers, and scaffold technologies, which have improved the safety of these stents in comparison with first-generation DES.
(RTTNews) - Medtronic plc (MDT) has received FDA approval for the Onyx Frontier drug-eluting stent for the treatment of patients with coronary artery disease, which is caused by plaque buildup on ...
A drug-eluting stent, or DES, is a small, metal mesh tube placed in a blocked coronary artery. The metal is coated in medicine and helps reopen your artery and keep it open. Stents are used to ...
Medtronic plc MDT announced the receipt of the FDA approval for the Onyx Frontier drug-eluting stent (DES). The Onyx Frontier DES is utilized for treating patients with coronary artery disease (CAD).
The Onyx Frontier™ drug-eluting stent offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent DUBLIN, May 13 ...
Medtronic plc MDT announced the receipt of the FDA approval for the Onyx Frontier drug-eluting stent (DES). The Onyx Frontier DES is utilized for treating patients with coronary artery disease (CAD).
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system - FOX8 WGHP
The Onyx Frontier™ drug-eluting stent offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent DUBLIN, May 13 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results